Franklin Resources Inc Nautilus Biotechnology, Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.64 - $4.84 $1.21 Million - $2.22 Million	-458,732 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.5 - $5.3 $3.38 Million - $5.12 Million	-966,250 Reduced 67.81%	458,732 $1.99 Million
Q4 2021 Feb 11, 2022	SELL	$4.45 - $6.21 $333,830 - $465,861	-75,018 Reduced 5.0%	1,424,982 $7.38 Million
Q3 2021 Nov 12, 2021	BUY	$6.14 - $10.1 $6.14 Million - $10.1 Million	1,000,000 Added 200.0%	1,500,000 $9.21 Million
Q2 2021 Aug 13, 2021	BUY	$9.04 - $14.19 $4.52 Million - $7.1 Million	500,000 New	500,000 $5.05 Million

63.9M

2.9K

500

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $324M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.